State of New Jersey Common Pension Fund D Sells 523,201 Shares of Global Medical REIT Inc. $GMRE
State of New Jersey Common Pension Fund D significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by selling 523,201 shares, lowering its total holdings to 114,550 shares valued at $3.86 million. Despite this, other institutional investors have either bought new positions or increased their holdings in the company. Global Medical REIT recently announced a quarterly dividend of $0.75 per share, representing an annualized dividend of $3.00 and an 8.4% yield.
Global Medical REIT (GMRE) Expected to Announce Earnings on Wednesday
Global Medical REIT (GMRE) is expected to release its Q4 2025 earnings after market close on Wednesday, February 25, 2026. Analysts project earnings of $1.02 per share and revenue of $37.442 million. The company recently paid a quarterly dividend of $0.75, implying an 8.2% yield, and institutional investors own 57.52% of its stock.
LSV Asset Management Lowers Position in Global Medical REIT Inc. $GMRE
LSV Asset Management significantly reduced its stake in Global Medical REIT (NYSE:GMRE) by 80.7% in Q3, selling 643,801 shares and retaining 154,099 shares. Despite this, other institutional investors like Geode Capital Management and Invesco Ltd. increased their positions. Analyst consensus on GMRE is a "Moderate Buy" with a $41.50 price target, though some recent ratings have been neutral or sell.
Trading the Move, Not the Narrative: (GMRE) Edition
This article provides an analysis of Global Medical Reit Inc. (GMRE), identifying a neutral near-term sentiment while mid-term sentiment shows strength despite potential stalling. It highlights a significant risk-reward short setup and offers institutional trading strategies like position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for investors.
Strategic Realignment Under a New Banner: Global Medical REIT Rebrands to Chiron Real Estate Inc.
Global Medical REIT is undergoing a significant strategic pivot, rebranding to Chiron Real Estate Inc. and unveiling a new corporate identity and ticker symbol "XRN" on February 23, 2026. This move, coinciding with their 2025 annual report, aims to reinforce their focus on the medical net-lease sector, acquiring and managing physician practices and outpatient facilities. Investors are anticipating details on capital deployment from a recent Series B preferred stock issuance and the company's operating objectives under the new brand.
Strategic Realignment Under a New Banner: Global Medical REIT Rebrands to Chiron Real Estate Inc.
Global Medical REIT is undergoing a major strategic pivot, rebranding to Chiron Real Estate Inc., effective February 23, 2026, with a new ticker symbol "XRN" on the NYSE. The company will maintain its core focus on the medical net-lease sector, acquiring and managing physician practices and outpatient facilities. The upcoming Q4 and full-year 2025 financial results announcement on February 25, followed by an analyst call on February 26, will provide further details on their growth ambitions and capital deployment from their recent Series B preferred stock issuance.
Alps Advisors Inc. Sells 106,865 Shares of Global Medical REIT Inc. $GMRE
Alps Advisors Inc. significantly reduced its stake in Global Medical REIT (GMRE) by 80% in Q3, selling over 106,000 shares and retaining a small position. Despite this, Global Medical REIT announced a quarterly dividend of $0.75, yielding 8.2%, and maintains a "Moderate Buy" consensus rating from analysts, though individual analyst opinions are mixed. Insider transactions show CEO Mark Okey Decker, Jr. recently purchased 10,000 shares, increasing his ownership.
Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast
Global Medical REIT Inc. (GMRE) announced it will release its Q4 and year-end 2025 financial results on February 25, 2026, after market close, followed by a conference call on February 26, 2026, at 9:00 a.m. Eastern Time. Coinciding with the results release, the company's previously announced name change to Chiron Real Estate Inc. will take effect, and calls will be streamed on its new website, chironre.com. GMRE currently operates as a net-lease medical REIT focused on acquiring and leasing healthcare facilities.
Penserra Capital Management LLC Sells 131,200 Shares of Global Medical REIT Inc. $GMRE
Penserra Capital Management LLC significantly reduced its stake in Global Medical REIT Inc. (GMRE) by selling 131,200 shares, decreasing its holdings by 79.3% in the third quarter. Despite this, Global Medical REIT maintains a "Moderate Buy" rating from analysts with an average price target of $41.50, and its CEO recently increased his personal ownership by purchasing additional shares. The company also declared a quarterly dividend of $0.75, representing an 8.2% annual yield.
A New Identity for Global Medical REIT: Rebranding as Chiron Real Estate
Global Medical REIT is rebranding as Chiron Real Estate Inc. to reflect a strategic shift in the evolving healthcare property sector. The company continues to prioritize shareholder returns through dividend distributions while navigating leadership changes on its board. Investors are awaiting the Q4 2025 financial results to assess the underlying business strength and the impact of the new strategic direction.
Global Medical REIT Announces Rebrand To Chiron Real Estate
Global Medical REIT Inc. (NYSE: GMRE) announced its rebranding to "Chiron Real Estate Inc.," effective February 23, 2026, with the new ticker symbol "XRN" on the NYSE. The name change reflects a redefined strategy focusing on delivering value at the intersection of care, capital, and real estate, inspired by Chiron from Greek mythology. This rebrand will not alter the company's organizational structure, stockholder rights, or REIT qualification.
Global Medical REIT to rebrand as Chiron Real Estate, adopt XRN ticker
Global Medical REIT Inc. (NYSE:GMRE) announced it will change its name to Chiron Real Estate Inc. and its ticker symbol to XRN on the NYSE, effective February 23, 2026. This rebranding is intended to align with the company's redefined strategy to deliver value at the intersection of care, capital, and real estate, inspired by Chiron from Greek mythology. The change will also affect its preferred stock ticker symbols and will coincide with the launch of its new corporate website, www.chironre.com.
Global Medical REIT to rebrand as Chiron Real Estate, adopt XRN ticker
Global Medical REIT Inc. (NYSE:GMRE) announced it will rebrand as Chiron Real Estate Inc. and trade under the new ticker XRN on the NYSE, effective February 23, 2026. This change reflects a redefined strategy focusing on the intersection of care, capital, and real estate, and will not affect the company's structure or REIT qualification. The company also recently priced a $50 million preferred stock offering and is undergoing board changes with the retirements of two long-serving directors in 2026.
Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.
Global Medical REIT Inc. (NYSE: GMRE) will rebrand as Chiron Real Estate Inc., effective February 23, 2026, and its common stock will trade under the new ticker symbol "XRN" on the NYSE. The rebranding reflects a redefined strategy and a new mission to deliver value at the intersection of care, capital, and real estate, inspired by the Greek mythological figure Chiron. This change will not affect the company's organizational structure, stockholder rights, or REIT qualification.
Global Medical REIT in Bethesda rebrands as Chiron Real Estate
Global Medical REIT, based in Bethesda, is rebranding as Chiron Real Estate Inc. This change follows Mark Decker Jr. taking over as president and CEO in June, after which he spent six months redefining the firm's strategy. The company owns over 5.2 million square feet of medical properties.
Global Medical REIT Unveils Rebrand
Global Medical REIT Inc. (NYSE: GMRE) announced it will change its name to "Chiron Real Estate Inc." and its ticker symbol to "XRN," effective February 23, 2026. This rebranding reflects a redefined strategy and a new mission to deliver value at the intersection of care, capital, and real estate. The company's preferred stock symbols will also change accordingly.
Global Medical REIT Unveils Rebrand
Global Medical REIT Inc. (NYSE: GMRE) announced its rebranding to "Chiron Real Estate Inc.," effective February 23, 2026, with its common stock trading under the new ticker symbol "XRN" on the NYSE. This change reflects a redefined strategy and mission, and the company plans to release an investor presentation outlining its 2026 strategic objectives with its fourth-quarter earnings. The rebranding also includes changing ticker symbols for its Series A and B Preferred Stocks.
Global Medical REIT to rebrand as Chiron Real Estate, adopt XRN ticker
Global Medical REIT Inc. announced its rebranding to Chiron Real Estate Inc. and adoption of the new NYSE ticker symbol XRN, effective February 23, 2026. The new name, inspired by Greek mythology, reflects the company's refreshed mission at the intersection of care, capital, and real estate, following a strategy reevaluation. The change will not impact the company's organizational structure, stockholder rights, or REIT qualification, and an investor presentation detailing 2026 strategic objectives will accompany its fourth-quarter earnings release.
From Global Medical REIT to Chiron: a myth-inspired real estate rebrand
Global Medical REIT Inc. (NYSE: GMRE) announced its rebranding to "Chiron Real Estate Inc.," effective February 23, 2026, with its stock subsequently trading under the new ticker symbol "XRN" on the NYSE. The name "Chiron," inspired by Greek mythology, reflects the company's refreshed mission to deliver value at the intersection of care, capital, and real estate, emphasizing integrity and thought leadership. This strategic rebrand will not impact the company's organizational structure, stockholder rights, or REIT qualification for U.S. federal income tax purposes.
(GMRE) Volatility Zones as Tactical Triggers
This article analyzes Global Medical REIT Inc. (GMRE) using AI models to suggest trading strategies. It highlights a potential 10.1% downside with a strong risk-reward short setup due to weak near-term sentiment. The analysis provides long, breakout, and short strategies with specific entry, target, and stop-loss zones for different risk profiles.
Universal Beteiligungs und Servicegesellschaft mbH Decreases Stock Holdings in Global Medical REIT Inc. $GMRE
Universal Beteiligungs und Servicegesellschaft mbH significantly reduced its stake in Global Medical REIT Inc. by 80% during the third quarter, now holding 32,613 shares valued at approximately $1.10 million. Despite this, Global Medical REIT reported strong Q3 earnings, beating analyst estimates, and has a dividend yield of 8.7%. Insider buying by CEO Mark Okey Decker Jr. also increased his holdings in the company.
2025 Global Medical REIT payouts: check new tax breakdown
Global Medical REIT Inc. (GMRE) has published information regarding the federal income tax treatment of its 2025 dividends for both common and Series A preferred stock on its website. The data for common dividends paid in January, April, and July 2025 has been adjusted due to a one-for-five reverse stock split effective September 19, 2025. Stockholders are advised to review their 1099 Forms and consult tax advisors for personal tax consequences.
Strs Ohio Sells 265,120 Shares of Global Medical REIT Inc. $GMRE
Strs Ohio reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 62.2% in the third quarter, selling 265,120 shares and retaining 161,080 shares valued at $5.43 million. Other institutional investors like Invesco Ltd. and Marshall Wace LLP increased their holdings, significantly impacting the stock's institutional ownership. Global Medical REIT announced a quarterly dividend of $0.75 and reported quarterly earnings that beat consensus estimates, despite challenges reflected in its negative PE ratio and recent analyst downgrades.
Global Medical REIT director Henry Cole to step down in 2026
Global Medical REIT Inc. announced that director Henry Cole will step down at the end of his term in 2026. Cole has been an Independent Director since the company's inception, holding several leadership roles. Additionally, board member Ronald Marston will also retire in 2026, marking significant leadership changes for the company.
Henry Cole to Step Down from Global Medical REIT Board
Henry Cole has announced his decision to step down from the Board of Directors of Global Medical REIT Inc. (NYSE: GMRE) at the conclusion of his current term in 2026. He has served as an Independent Director since the company's inception, holding various key roles including Lead Independent Director and Chair of the Compensation and ESG Committees. The Board, led by Chairman Jeffrey Busch, expressed gratitude for Cole's significant contributions to the company's growth and guidance.
Global Medical REIT director Henry Cole to step down in 2026
Global Medical REIT Inc. announced that board member Henry Cole will retire at the end of his term in 2026. Cole has been an Independent Director since the company's inception, holding key roles including Lead Independent Director and Chair of the Compensation and ESG Committees. This leadership change aligns with other recent developments, such as a $50 million public offering and the upcoming retirement of another director, Ronald Marston.
Intrua Financial LLC Cuts Holdings in Global Medical REIT Inc. $GMRE
Intrua Financial LLC significantly reduced its stake in Global Medical REIT (GMRE) by 80.7% in Q3 2025, selling 39,919 shares, though insiders like CEO Mark Okey Decker Jr. have recently increased their holdings. GMRE offers an 8.3% dividend yield and analysts maintain a "Moderate Buy" consensus with a $41.50 price target. The company reported strong Q3 earnings, beating estimates, and has provided optimistic FY2025 EPS guidance.
LDR Capital Management LLC Sells 160,260 Shares of Global Medical REIT Inc. $GMRE
LDR Capital Management LLC significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 91.5% in the third quarter, leaving the firm with 14,846 shares. Despite this large sale, other institutional investors have increased their holdings, and Global Medical REIT's CEO recently bought 10,000 shares, signaling insider confidence. The company reported strong Q3 EPS and declared a quarterly dividend of $0.75 per share, yielding 8.4%.
Global Medical REIT Inc. $GMRE Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 80.3% in the third quarter, selling 53,926 shares and retaining 13,231 shares. Despite this, other institutional investors increased their holdings, and CEO Mark Okey Decker Jr. bought 10,000 shares, increasing his total ownership. Global Medical REIT currently pays a quarterly dividend of $0.75, equating to an 8.3% yield, and analysts have issued ratings ranging from "Strong Buy" to "Sell," with an average "Moderate Buy" rating.
Nisa Investment Advisors LLC Sells 28,491 Shares of Global Medical REIT Inc. $GMRE
Nisa Investment Advisors LLC significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 83.4%, selling 28,491 shares and retaining 5,668 shares valued at $199,000. Despite this institutional selling, CEO Mark Okey Decker Jr. acquired 10,000 shares, increasing his ownership by 28.8% and signaling insider confidence. Global Medical REIT also offers an 8.3% dividend yield and has provided optimistic FY2025 EPS guidance, while analyst ratings average a "Moderate Buy" with a $41.50 price target.
OVERSEA CHINESE BANKING Corp Ltd Sells 63,657 Shares of Global Medical REIT Inc. $GMRE
OVERSEA CHINESE BANKING Corp Ltd significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by selling 63,657 shares, decreasing its total holding to 15,045 shares. Meanwhile, CEO Mark Okey Decker, Jr. increased his personal stake by purchasing 10,000 shares, indicating insider confidence. The company also announced a quarterly dividend of $0.75 per share, leading to an annualized yield of 8.3%.
Global Medical REIT launches Series B preferred stock offering
Global Medical REIT has announced the launch of its Series B preferred stock offering. This move indicates the company's efforts to raise capital through preferred equity, which can provide a steady income stream for investors. The details of the offering, such as terms and quantity, would typically be outlined in the official announcement.
Global Medical REIT Inc. (NYSE:GMRE) Given Average Recommendation of "Moderate Buy" by Brokerages
Global Medical REIT Inc. (NYSE:GMRE) has received a "Moderate Buy" consensus recommendation from seven brokerages, with an average 12-month price target of $41.50. The CEO recently increased his stake in the company by purchasing 10,000 shares, and insiders collectively own 8.5% of the stock. GMRE also declared a quarterly dividend of $0.75, representing an 8.5% yield, and reported Q3 EPS of $1.12, beating estimates.
141,934 Shares in Global Medical REIT Inc. $GMRE Acquired by Peregrine Capital Management LLC
Peregrine Capital Management LLC recently acquired 141,934 shares of Global Medical REIT Inc. (NYSE:GMRE) worth approximately $4.79 million, representing a 1.06% stake in the company. Several other institutional investors also adjusted their holdings, with 57.52% of the stock now owned by hedge funds and institutions. Analysts have given GMRE an average "Moderate Buy" rating with a target price of $41.50, and the company recently declared a quarterly dividend of $0.75 per share.
Global Medical REIT Inc. $GMRE Position Trimmed by Asset Management One Co. Ltd.
Asset Management One Co. Ltd. significantly reduced its stake in Global Medical REIT Inc. by 80% in Q3, selling over 71,000 shares. Despite this, other institutional investors have modified their positions, with some increasing their holdings. The article also highlights an insider purchase by CEO Mark Okey Decker Jr., the company's dividend yield of 8.5%, its recent earnings performance, and updated analyst ratings.
D.A. Davidson & CO. Reduces Stock Holdings in Global Medical REIT Inc. $GMRE
D.A. Davidson & Co. significantly reduced its stake in Global Medical REIT Inc. (NYSE: GMRE) by 80.5% in the third quarter of 2025. Despite this, other institutional investors increased their positions, and the company announced a quarterly dividend of $0.75 per share. The CEO also acquired additional shares, increasing insider ownership to 8.5%.
1 REIT To Sell And 1 Better REIT To Buy
The article discusses an active investment strategy for REITs, emphasizing that individual REITs are often mispriced, providing opportunities for significant returns. The author, Jussi Askola, CFA, identifies one REIT to sell and another to buy as a clear example of this inefficiency within the sector. He leverages his High Yield Landlord investing group to share real-world portfolio insights and top picks for 2026.
How Global Medical Reit Inc. (GMRE) Affects Rotational Strategy Timing
This article analyzes Global Medical Reit Inc. (GMRE) using AI models, highlighting mixed sentiment and choppy conditions across different time horizons. It provides specific institutional trading strategies for long, breakout, and short positions, along with multi-timeframe signal analysis indicating support and resistance levels. The report also details AI-generated signals for GMRE, emphasizing risk-reward ratios and personalized alerts for subscribers.
Global Medical REIT Inc. (NYSE:GMRE) Given Consensus Rating of "Moderate Buy" by Analysts
Seven brokerages have given Global Medical REIT Inc. (NYSE:GMRE) a consensus "Moderate Buy" rating, with an average 12-month price target of $41.50. The company recently declared a quarterly dividend of $0.75, announced an EPS beat for the last quarter ($1.12 vs. $1.05), and CEO Mark Okey Decker Jr. increased his stake by purchasing additional shares.
Global Medical REIT Announces Preferred Stock Offering
Global Medical REIT Inc. announced its intention to launch an underwritten public offering of its Series A Cumulative Redeemable Preferred Stock. The company plans to use the net proceeds from this offering for general corporate purposes, including potential acquisitions of healthcare facilities and general working capital. Stifel, Nicolaus & Company, Inc. is acting as the sole book-running manager for the offering.
Global Medical REIT announces board retirement and Q4 dividends
Global Medical REIT Inc. announced that board member Ronald Marston will retire in 2026 and declared its fourth-quarter 2025 dividends. Common stockholders will receive $0.75 per share, Series A Preferred Stockholders $0.46875 per share, and Series B Preferred Stockholders an initial pro rata dividend of $0.388 per share. The company, which acquires and leases healthcare facilities, appears undervalued based on InvestingPro analysis.
Global Medical REIT Inc. (NYSE:GMRE) to Issue Quarterly Dividend of $0.75
Global Medical REIT Inc. (NYSE:GMRE) has announced a quarterly dividend of $0.75 per share, with an ex-dividend date of December 19th and payment on January 9th. This represents an annualized yield of 9.2%, but the dividend's sustainability is questionable given a reported payout ratio of 6,000% and a projected future payout ratio of 357%. CEO Mark Okey Decker Jr. recently increased his stake by purchasing 10,000 shares.
Global Medical prices $50M in new preferred stock offering priced at $25.00 a share
Global Medical REIT, Inc. announced the pricing of its underwritten public offering of 2,000,000 shares of 8.00% Series A Cumulative Redeemable Preferred Stock at $25.00 per share, totaling $50 million. The company has also granted the underwriters a 30-day option to purchase up to an additional 300,000 shares. Net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $48.3 million.
Global Medical REIT Director Ronald Marston to Retire
Ronald Marston, a director of Global Medical REIT Inc. (GMRE), has announced his retirement effective at the company's 2026 Annual Meeting of Stockholders. This transition is not due to any disagreements with the company's operations. While analysts currently rate GMRE as a "Hold" with a $33.00 price target, TipRanks' AI Analyst Spark identifies the stock as "Neutral" due to financial performance challenges despite positive insights into debt management and NOI growth.
Global Medical REIT (NYSE: GMRE) sets Q4 dividends as director Ronald Marston plans exit
Global Medical REIT Inc. (NYSE: GMRE) announced that Ronald Marston will retire from its Board of Directors at the end of his current term in 2026. The company also declared its 2025 fourth-quarter common stock dividend of $0.75 per share, payable on January 9, 2026, and quarterly cash dividends for both Series A and Series B Cumulative Redeemable Preferred Stocks, payable on February 2, 2026.
Global Medical REIT Announces Director Retirement
Global Medical REIT Inc. (GMRE) announced that Mr. Ronald Marston will retire from his director position, effective at the 2026 Annual Meeting of Stockholders. His decision was not due to any disagreement with the company. This information was based on an SEC filing from December 4, 2025.
Global Medical REIT (NYSE: GMRE) starts Series B preferred offering, to list as GMRE-PrB
Global Medical REIT Inc. announced a public offering of its Series B Cumulative Redeemable Preferred Stock, which it intends to list on the New York Stock Exchange under the symbol "GMRE-PrB." The company plans to use the net proceeds for general corporate purposes, including funding new acquisitions and repaying existing debt. Raymond James, BMO Capital Markets, Stifel, and Baird are serving as book-running managers for the offering.
Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends
Global Medical REIT Inc. (GMRE) announced the retirement of Ronald Marston from its Board of Directors, effective at the end of his current term in 2026. The company also declared its 2025 fourth quarter common dividend of $0.75 per share, payable on January 9, 2026, and quarterly cash dividends for its Series A and Series B Preferred Stocks, both payable on February 2, 2026. This announcement includes details on preferred dividend payments and Global Medical REIT's business as a net-lease medical REIT.
Global Medical REIT Shares Slip After Announcing Preferred Stock Offering
Global Medical REIT shares experienced a decline following the announcement of a proposed public offering of its 7.50% Series B Cumulative Redeemable Preferred Stock. The offering price is set at $25.00 per share. The company noted that the offering's lead book-running manager is Stifel, with B. Riley Securities and Raymond James also participating as book-running managers.
Vinson & Elkins Advises Global Medical REIT Inc. on Series B Preferred Stock Offering
Vinson & Elkins advised Global Medical REIT Inc. on an underwritten public offering of 2,000,000 shares of its 8.00% Series B Preferred Stock, priced at $25.00 per share. The Company also granted underwriters an option to purchase up to an additional 300,000 shares. The offering successfully closed on November 20, 2025.
